Related Experiment Video
Updated: Jan 19, 2026

Real-Time Monitoring of Neurocritical Patients with Diffuse Optical Spectroscopies
Published on: November 19, 2020
Clinical evolution and survival of neurocritical patients
Palloma Lopes de Arruda1, Rafaela de Oliveira Xavier1, Gerlene Grudka Lira1
1Universidade de Pernambuco, Campus Petrolina, Petrolina, PE, Brasil.
Objective:
To evaluate the clinical evolution and survival of neurocritical patients in Hospital Units.
Method:
Cohort with hospitalized patients in follow-up treatment in public and private hospitals between September 2012 and June 2016. Data were initially analyzed from descriptive and inferential statistics. The Kaplan-Meier indicator was applied as a form of survival analysis. The Cox proportional hazards regression model was used to analyze the prognostic factors by calculating the hazard ratio.
Results:
Participation of 1,289 patients in the study. Patients with a higher score on the Glasgow Coma Scale presented greater survival, and the one-point increase in the scale score corresponded to 42% improvement in their survival. In the analysis of survival, sex and the use of vasoactive drugs showed a significant difference.
Conclusion:
Female patients with a better score on the Glasgow Coma Scale and using vasoactive drugs had higher survival rates.
More Related Videos
Related Concept Videos
07:12Real-Time Monitoring of Neurocritical Patients with Diffuse Optical Spectroscopies
The Evidence for Evolution
Convergent Evolution
08:56Clinical Assessment of Spatiotemporal Gait Parameters in Patients and Older Adults
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
05:16Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

